CST: 28/09/2016 06:54:01   

Ropharma Brings Quality, Natural Products to US Market

181 Days ago

Romanian Company Uses Natural Ingredients Based on Traditional Recipes in Supplements

BOCA RATON, FL --(Marketwired - March 30, 2016) - Ropharma, a Romanian company with a focus on producing and distributing innovative natural pharmaceuticals, that contain ingredients based on natural active principles.

The R&D, the manufacturing, the wholesale and retail distribution, the medical services and clinical studies are Ropharma's operating integrated business model.

Starting with 2016, Ropharma announced its product line is now available for sale in the US Market.

The Ropharma portfolio includes innovative products that contain ingredients based on natural active principles, molecules obtained in over 10 years of laborious research programs, manufactured according to GMP European Standards for medicinal products.

"I am pleased to announce Ropharma is now distributing and marketing its natural pharmaceuticals in the US Market," said Ropharma Business Advisor to CEO, Mihai Corneanu.

The Ropharma product portfolio have the highest efficiency, superior tolerability, powerful and fast effect due to the synergistic action of the natural components in the composition.

"Ropharma wants to be a partner in health maintainance, to offer patients new solutions and ideas, to understand them, and give them the attention and support they need," said Ropharma Business Advisor to CEO, Mihai Corneanu.

Ropharma targets to provide solutions for a wide variety of needs, among patients, from the children product range, products for mothers, to vitamins and minerals that may be a way of supplementing a balanced diet, designed for all age categories.

The company president, Mihai Miron, Doctor Pharmacist, was the first pharmacist and Romanian entrepreneur who produced medicinal products in the private system, since 1989.

Mihai Miron is additionally the owner of the original ParaSinus formula, one of the most popular and well-known medicinal products in Romania with over 6 million boxes sold in 2015.

In 1998, he established a partnership and sold part of Europharm to SmithKline Beecham, which was the largest Romanian transaction from that year. The transaction was completed in 2003, when all shares were sold to GlaxoSmithKline. During that period, Mihai Miron was the Country Manager for Romania and Moldova, and for a period of time, was the Vice President for Central and Eastern Europe.

Ropharma owns two manufacturing facilities of medicinal products and food supplements, and a milk powder factory. The factories have a tradition of over 30 years on the market, with harmonized production processes at GMP European Standards for medicinal products manufacturing.

The product portfolio includes specific products as well, products designed exclusively for therapeutic areas such as: anti-diabetes, cholesterol adjustment, urinary tract care, anti-cough, ointments, liver-protective, oral pharynx disinfectants, antioxidants, and anti-stress products.

These products contain standardized extracts in active principles, have original combinations with a synergistic effect in the composition of the products.

The production processes at GMP European Standards for medicinal products, controlled by the best specialists in the field are Ropharma's exceptional product quality guarantee.

"The products from our portfolio have not only a preventive role, but also are beneficial in specific treatments, having scientifically proven effects, sustained by clinical studies," said Ropharma Business Advisor to CEO, Mihai Corneanu.

"The traditional recipe in our pharmaceutical products have been proven effective by the test of time," said Corneanu.

Our patients appreciate the obtained results after the treatments, the quality of the products we offer and the increased care given to our exceptional production conditions.

"Now the American consumer has the possibility to treat common sicknesses and maintain a healthy balance naturally, without synthetic drugs that often have adverse effects."

To learn more about Ropharma and its wide range of products, please visit http://www.ropharma.ro/.

Please direct inquiries to:
Alex Press
321-614-4293
apress@inhealthmedia.com